Discovery Projects - Grant ID: DP0881708

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/DP0881708

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Engineering of co-crystal drug molecules for pharmaceutical aerosols. This project will enable Australia to become a world leader in treatment of respiratory diseases. The Australian financial burden of respiratory diseases is currently estimated as $900m with significant impact on infrastructure (through regular clinical visits, hospitalisation and workforce loss). The global market for the treatment of COPD is currently $32 billion and is expected to increase significantly by 2010. The positioning of an Australian research as a world leader in the development of new treatments will have significant national benefit, whilst the sector will benefit for scientific advancements that arise during this project.

Funded Activity Details

Start Date: 02-06-2008

End Date: 16-12-2011

Funding Scheme: Discovery Projects

Funding Amount: $300,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Composite Materials | Pharmacology and Pharmaceutical Sciences | Pharmaceutical Sciences And Pharmacy | Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

Respiratory system and diseases (incl. asthma) | Human pharmaceutical products | Treatments (e.g. chemicals, antibiotics) |

Other Keywords

Composite Materials | Human pharmaceutical products | Pharmaceutical Sciences And Pharmacy | Pharmacology and Pharmaceutical Sciences | Respiratory Diseases | Respiratory system and diseases (incl. asthma) | Treatments (e.g. chemicals, antibiotics)

Related Links